成人脓毒症与脓毒性休克表型分型方法:范围综述
该范围综述检索Medline和Embase,纳入17项使用聚类方法识别脓毒症或脓毒性休克表型的临床研究,排除会议摘要、文献综述、评论、致编辑信和体外研究,并用经验证偏倚风险工具评估观察性队列和横断面研究质量。表型分型最常基于临床非基因组变量按炎症反应程度和凝血功能障碍分组,5篇基于基因组或转录组数据聚类,7篇生成对脓毒症治疗反应不同的患者亚组;各研究间聚类临床特征及其与死亡率和治疗反应的关联异质性大,17篇中仅9篇评估了效度,妨碍结果汇总及得出脓毒症表型、预后能力和治疗反应关联的普遍结论。结论认为分型方法可识别高危患者和可能对靶向治疗应答良好者,研究质量中等,但实现普适性和临床影响需外部验证并与替代方法直接比较。
要点
- 17项研究中仅9项评估了表型效度,结果异质性大,无法汇总得出脓毒症表型与预后、治疗反应关联的普遍结论。
- 最常用的分型依据是临床非基因组变量反映的炎症反应程度和凝血功能障碍,5篇研究基于基因组或转录组数据聚类。
- 7篇研究生成的患者亚组对脓毒症治疗反应不同,提示表型分型可能识别高概率应答靶向治疗者。
- 研究质量评为中等(fair),作者认为实现普适性和临床影响需外部验证并与替代方法直接比较。
适用人群与场景
- 成人脓毒症或脓毒性休克患者。
- 纳入标准:描述脓毒症或脓毒性休克并使用任何聚类方法识别脓毒症表型的临床研究。
- 排除:会议摘要、文献综述、评论、致编辑信和体外研究。
研究设计与关键结果
- 研究类型:范围综述,检索Medline和Embase,从17项研究中提取人群、方法学、验证和表型特征。
- 表型方法:最常基于临床非基因组变量按炎症反应程度和凝血功能障碍分组;5篇文章基于基因组或转录组数据聚类;7篇文章生成对脓毒症治疗反应不同的患者亚组。
- 异质性与验证:各研究间聚类临床特征及其与死亡率和治疗反应的关联异质性大;17篇中9篇评估了效度,妨碍结果汇总分析和得出脓毒症表型、预后能力及治疗反应关联的普遍结论。
- 结论:表型分型方法可识别高危患者和那些高概率对靶向治疗应答良好者;研究质量中等(fair)。
证据类型、等级与局限
- 证据类型:范围综述(scoping review),纳入17项临床研究,采用经验证偏倚风险工具评估观察性队列和横断面研究质量。
- 研究质量:中等(fair)。
- 局限:各研究间聚类临床特征及其与死亡率和治疗反应的关联异质性大,妨碍汇总分析;17篇中仅9篇评估效度;作者认为需外部验证和与替代方法直接比较以实现普适性和临床影响。
对床旁实践的改变
- 作者认为,脓毒症表型分型方法可识别高危患者和那些高概率对靶向治疗应答良好者。
- 作者认为,实现脓毒症表型分型的普适性和临床影响需外部验证和与替代方法直接比较。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Despite its heterogeneous phenotypes, sepsis or life-threatening dysfunction in response to infection is often treated empirically. Identifying patient subgroups with unique pathophysiology and treatment response is critical to the advancement of sepsis care. However, phenotyping methods and results are as heterogeneous as the disease itself. This scoping review evaluates the prognostic capabilities and treatment implications of adult sepsis and septic shock phenotyping methods.
DATA SOURCES: Medline and Embase.
STUDY SELECTION: We included clinical studies that described sepsis or septic shock and used any clustering method to identify sepsis phenotypes. We excluded conference abstracts, literature reviews, comments, letters to the editor, and in vitro studies. We assessed study quality using a validated risk of bias tool for observational cohort and cross-sectional studies.
DATA EXTRACTION: We extracted population, methodology, validation, and phenotyping characteristics from 17 studies.
DATA SYNTHESIS: Sepsis phenotyping methods most frequently grouped patients based on the degree of inflammatory response and coagulopathy using clinical, nongenomic variables. Five articles clustered patients based on genomic or transcriptomic data. Seven articles generated patient subgroups with differential response to sepsis treatments. Cluster clinical characteristics and their associations with mortality and treatment response were heterogeneous across studies, and validity was evaluated in nine of 17 articles, hindering pooled analysis of results and derivation of universal truths regarding sepsis phenotypes, their prognostic capabilities, and their associations with treatment response.
CONCLUSIONS: Sepsis phenotyping methods can identify high-risk patients and those with high probability of responding well to targeted treatments. Research quality was fair, but achieving generalizability and clinical impact of sepsis phenotyping will require external validation and direct comparison with alternative approaches.
参考来源
- Li H, Markal A, Balch JA, et al. Methods for Phenotyping Adult Patients in Sepsis and Septic Shock: A Scoping Review. Crit Care Explor. 2022. PMID: 35372844. doi:10.1097/CCE.0000000000000672
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。